Bifidobacterium bifidum
- Generic Name
- Bifidobacterium bifidum
- Drug Type
- Biotech
- Unique Ingredient Identifier
- WN5C16297P
Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children with Leukemia
Phase 2
- Conditions
- Gastrointestinal DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaProbiotics
- Interventions
- Dietary Supplement: Placebo
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- National Institute of Pediatrics, Mexico
- Target Recruit Count
- 120
- Registration Number
- NCT06560879
- Locations
- 🇲🇽
National Institute of Pediatrics, Mexico City, Coyoacan, Mexico
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath